Yüklüyor......
3-(Fur-2-yl)-10-(2-phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a Novel Adenosine Receptor Antagonist with A(2A)-Mediated Neuroprotective Effects
[Image: see text] In this study, compound FTBI (3-(2-furyl)-10-(2-phenylethyl)[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one) was selected from a small library of triazinobenzimidazole derivatives as a potent A(2A) adenosine receptor (AR) antagonist and tested for its neuroprotective effects against...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Chemical Society
2011
|
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3369784/ https://ncbi.nlm.nih.gov/pubmed/22860174 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cn200036s |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|